FIELD: chemistry.
SUBSTANCE: invention relates to a compound selected from the group comprising compounds 2-8, 2-7, 3-6, 3-5, 4-12, 4-11, 8-8, 8-7, 11-16, 11-15, where the absolute stereochemical configuration of the compound is as shown in the structural formulae and to a pharmaceutically acceptable salt thereof. Invention also relates to a pharmaceutical composition.
, , 
,
, 
, 
,
, 
, 
,
.
EFFECT: obtaining novel compounds having NMDA receptor modulator properties.
12 cl, 2 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2014 |
|
RU2754534C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
| COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
| COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2015 |
|
RU2733756C2 |
| OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2742333C2 |
| COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
| OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2744267C2 |
